Brief: Aequus Pharmaceuticals enters into agreement with Santen Pharmaceutical's unit

Aequus Pharmaceuticals

13/06/2017 14:07

June 13 (Reuters) - Aequus Pharmaceuticals Inc  AQS.V - 
    * Has entered into an exclusive agreement in Canada with a 
unit of Santen Pharmaceutical 
    * Under agreement, Aequus and Santen will plan to 
co-commercialize an undisclosed ophthalmology therapeutic 
product 
    * Aequus Pharmaceuticals - as per agreement, santen will be 
responsible for product manufacturing, distribution, co will be 
responsible for field activities 
    * Net product revenues will be split between aequus and 
santen over a ten-year term 
 
Source text for Eikon:  ID:nMKWyPXFga  
Further company coverage:  AQS.V  
 
 ((bangalore.newsroom@thomsonreuters.com;))